Thus, we evaluated whether extracellular ATP levels were decreased by conversion to ADO, known to protect CLL B cells from spontaneous apoptosis by binding and activating the ADO receptor P1A2A [40]. The gene discussed is ADO; the disease is B-cell chronic lymphocytic leukemia.